— Why it moved
Why SGRX Stock Spiked and Faded Today — October 30, 2026
Sangrix Inc. popped after hours on news of debt converted above market price, but the squeeze evaporated quickly.
What moved SGRX stock
Sangrix is a micro-cap biotech penny stock trying to avoid a Nasdaq delisting. An afternoon SEC filing showed noteholders converted $3.3 million in debt into equity at $1.63 per share. Retail chased the implied premium, though converting debt ultimately just creates more stock.
The mechanics
A tight float of 730,450 shares made the ticker extremely volatile once eyes turned to the filing. Over 79 million shares rotated through a shell of a company with a market cap under $1.5 million.
SGRX by the numbers
The alert window
The alert dropped at 3:54 PM at $0.7712. Anyone taking it had to absorb a 7.7% drawdown down to $0.7118 before the late pop hit $1.00 at 4:11 PM in after-hours. That gave a 17-minute window for a 29.7% maximum move before liquidity dried up.
How SGRX's move ended
It gave up the gains fast, closing at $0.7282 for a 5.6% loss from the alert. Dilution via note conversions combined with an upcoming reverse split vote leaves little reason to hold.
The tell: Debt conversions priced above market spark short squeezes, but new shares hitting the float always win out.